Number of Shares
223.00
Current Holdings Value*
$123,530.00
% of Portfolio
2.04%
Total Estimate Gain
$117,328.23
% of Total Estimate Gain
77.16%

BlackRock Defensive Advantage U.S. Fund's Eli Lilly and Co Holding Summary

As of 2023-10-31, BLACKROCK FUNDS held 223.00 shares of Eli Lilly and Co(LLY), totaling $123,530.00. This investment constitutes 2.04% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Eli Lilly and Co(LLY) stock.

The initial trade took place in 2021Q1. And since then BlackRock Defensive Advantage U.S. Fund has made 6 purchases of LLY, at an average price of $294.10, for a total of 517.00 shares. In addition, there have been 4 sales at an average price of $305.34 for 294.00 shares. Based on historical transaction data and LLY's current price of $805.43, BlackRock Defensive Advantage U.S. Fund's estimated gain on his LLY holdings is $117,328.23, reflecting a 77.16% gain to date.

BlackRock Defensive Advantage U.S. Fund LLY ($805.43) Holding Chart

BlackRock Defensive Advantage U.S. Fund LLY ($805.43) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1